These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35182811)

  • 21. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
    Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
    J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T
    Louapre C; Govindarajan ST; Giannì C; Madigan N; Nielsen AS; Sloane JA; Kinkel RP; Mainero C
    Neuroimage Clin; 2016; 12():879-886. PubMed ID: 27872810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early putamen hypertrophy and ongoing hippocampus atrophy predict cognitive performance in the first ten years of relapsing-remitting multiple sclerosis.
    Morelli ME; Baldini S; Sartori A; D'Acunto L; Dinoto A; Bosco A; Bratina A; Manganotti P
    Neurol Sci; 2020 Oct; 41(10):2893-2904. PubMed ID: 32333180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered brain network function during attention-modulated visual processing in multiple sclerosis.
    Veréb D; Tóth E; Bozsik B; Király A; Szabó N; Kincses B; Kocsis K; Faragó P; László V; Bencsik K; Klivényi P; Kincses ZT
    Mult Scler; 2021 Aug; 27(9):1341-1349. PubMed ID: 33016839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brief International Cognitive Assessment for Multiple Sclerosis scores are associated with the cortical thickness of specific cortical areas in relapsing-remitting patients.
    Davion JB; Lopes R; Jougleux C; Viard R; Dumont J; Leclerc X; Outteryck O
    Rev Neurol (Paris); 2022 Apr; 178(4):326-336. PubMed ID: 34657733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
    Lozano-Soto E; Cruz-López ÁJ; Gutiérrez R; González M; Sanmartino F; Rashid-Lopez R; Espinosa-Rosso R; Forero L; González-Rosa JJ
    Arch Clin Neuropsychol; 2021 May; 36(4):475-484. PubMed ID: 33067616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis.
    Yam C; Merlo D; Stankovich J; Darby D; Gresle M; Kalincik T; Kilpatrick TJ; Lechner-Scott J; Taylor B; Barnett M; Butzkueven H; van der Walt A
    Mult Scler Relat Disord; 2020 Aug; 43():102212. PubMed ID: 32474286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery of cognitive function after relapse in multiple sclerosis.
    Benedict RH; Pol J; Yasin F; Hojnacki D; Kolb C; Eckert S; Tacca B; Drake A; Wojcik C; Morrow SA; Jakimovski D; Fuchs TA; Dwyer MG; Zivadinov R; Weinstock-Guttman B
    Mult Scler; 2021 Jan; 27(1):71-78. PubMed ID: 31971066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical quantitative MRI parameters are related to the cognitive status in patients with relapsing-remitting multiple sclerosis.
    van Wijnen A; Petrov F; Maiworm M; Frisch S; Foerch C; Hattingen E; Steinmetz H; Klein JC; Deichmann R; Wagner M; Gracien RM
    Eur Radiol; 2020 Feb; 30(2):1045-1053. PubMed ID: 31602513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating levels of interleukin-17A, tumor necrosis factor-alpha, interleukin-18, interleukin-10, and cognitive performance of patients with relapsing-remitting multiple sclerosis.
    Trenova AG; Slavov GS; Draganova-Filipova MN; Mateva NG; Manova MG; Miteva LD; Stanilova SA
    Neurol Res; 2018 Mar; 40(3):153-159. PubMed ID: 29297273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
    Ruet A; Deloire MS; Charré-Morin J; Hamel D; Brochet B
    Mult Scler; 2013 Oct; 19(12):1665-72. PubMed ID: 23459569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the motor cortical quadripulse transcranial magnetic stimulation (QPS) on the contralateral motor cortex and interhemispheric interactions.
    Tsutsumi R; Hanajima R; Terao Y; Shirota Y; Ohminami S; Shimizu T; Tanaka N; Ugawa Y
    J Neurophysiol; 2014 Jan; 111(1):26-35. PubMed ID: 24108795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
    Hegedüs K; Kárpáti J; Iljicsov A; Simó M
    Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ApoE4-positive multiple sclerosis patients are more likely to have cognitive impairment: a cross-sectional study.
    Mashayekhi F; Sadigh-Eteghad S; Naseri A; Asadi M; Abbasi Garravnd N; Talebi M
    Neurol Sci; 2022 Feb; 43(2):1189-1196. PubMed ID: 34120271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortical M1 plasticity and metaplasticity in patients with multiple sclerosis.
    Baione V; Belvisi D; Cortese A; Cetta I; Tartaglia M; Millefiorini E; Berardelli A; Conte A
    Mult Scler Relat Disord; 2020 Feb; 38():101494. PubMed ID: 31715502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Validation in Arabic and Lebanese Normative Values.
    Darwish H; Zeinoun P; Farran N; Ghusn H; Yamout B; Khoury SJ
    J Int Neuropsychol Soc; 2022 Jan; 28(1):94-103. PubMed ID: 33563350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis.
    Polychroniadou E; Bakirtzis C; Langdon D; Lagoudaki R; Kesidou E; Theotokis P; Tsalikakis D; Poulatsidou K; Kyriazis O; Boziki M; Papadopoulos G; Boura E; Sintila L; Hatzigeorgiou S; Ziamos C; Ioannidis P; Karacostas D; Grigoriadis N
    Mult Scler Relat Disord; 2016 Sep; 9():68-72. PubMed ID: 27645348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inclusion of the Symbol Digit Modalities Test in a revised assessment of 'no evidence of disease activity-4 (NEDA-4)' in Latin-American patients with multiple sclerosis.
    Guevara C; Villa E; Diaz V; Garrido C; Martinez M; Orellana P; Alarcón P; Silva-Rosas C; Barker GJ; Kempton MJ; de Grazia J
    Mult Scler Relat Disord; 2020 Jul; 42():102076. PubMed ID: 32361478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new assessment tool for patients with multiple sclerosis from Spanish-speaking countries: validation of the Brief International Cognitive Assessment for MS (BICAMS) in Argentina.
    Vanotti S; Smerbeck A; Benedict RH; Caceres F
    Clin Neuropsychol; 2016 Oct; 30(7):1023-31. PubMed ID: 27668977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.